As of January 22, 2025, Akeso (9926.HK) has a market cap of $7.22 billion USD. According to our data, Akeso is ranked No.2124 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $7.22 B |
3.22%
|
Dec 31, 2024 | $6.99 B |
30.71%
|
Dec 29, 2023 | $5.35 B |
7.91%
|
Dec 30, 2022 | $4.96 B |
26.47%
|
Dec 31, 2021 | $3.92 B |
-10.76%
|
Dec 31, 2020 | $4.39 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Jiangsu Hengrui Medicine
600276.SS
|
$38.98 B |
-0.614 B
|
China
|
Zai Lab
ZLAB
|
$3.04 B |
0.126 B
|
China
|
Mindray
300760.SZ
|
$38.25 B |
-1.002 B
|
China
|
Hualan Biological Engineering
002007.SZ
|
$3.99 B |
-0.010 B
|
China
|
Sino Biopharmaceutical
1177.HK
|
$6.77 B |
-0.023 B
|
China
|
Market Cap | = | 9926.HK Stock Price | * | 9926.HK Shares Outstanding |
= | $8.04 | * | 0.90 B | |
= | $7.22 B |